Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients

NCT06492798 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Long COVID
Post-Acute COVID-19 Syndrome

Interventions

DRUG: umbilical cord mesenchymal stem cell

Sponsor

Changhai Hospital